Daniel D Anselm1, Natalia Rodriguez Genaro2, Adrian Baranchuk1. 1. Queen's University, Kingston General Hospital, Departamento de Cardiologia, Eletrofisiologia e Ritmo Cardíaco, Ontario, Canada. 2. Hospital General de Agudos Donación Francisco Santojanni, Buenos Aires, Argentina.
We read with great interest the case report by Gazzoni et al[1] regarding a Brugada ECG pattern induced by hypokalemia.
This paper is important because it contributes to the growing body of literature
describing Brugada Phenocopies (BrP)[2-5].Briefly, BrP are characterized by ECG patterns that are identical to type-1 or type-2
Brugada ECG patterns despite the absence of true congenital Brugada Syndrome (BrS). BrP
are induced by various clinical circumstances including: hypokalemia, hyperkalemia,
hypothermia, myocardial ischemia, and pulmonary embolism. We have established six
etiological categories of BrP[2-4] along with a systematic approach to
diagnose BrP[3] by excluding sodium
channel dysfunction in the myocardium. The presented case by Gazzoni et al[1] would possibly qualify under category (i)
metabolic conditions; however, further analysis of this case report is required.Specifically, this is the first report of a possible BrP induced by hypokalemia in
association with hypokalemic periodic paralysis (HPP). Patients with HPP are known to
have gene mutations resulting in abnormalities of either dihydropyridine sensitive
calcium channels or sodium channels (SCN4A) in skeletal muscles.
Patients with true congenital BrS have mutations in the myocardial
sodium channels (SCN5A) and the association in this patient is most intriguing and
remains speculative. The type-1 "coved" Brugada ECG pattern observed in this patient
could have been induced by the transient serum hypokalemia (which would qualify this as
a BrP) or there may be a congenital dysfunction in this patient's sodium channels in
both his skeletal muscles (HPP) and myocardium resulting in the ECG abnormalities.
Therefore, we recommend to the authors that a myocardial provocative challenge with a
sodium channel blocker such as procainamide, ajmaline, or flecainide be performed to
rule out myocardial sodium channel dysfunction. In addition, we also suggest that future
reports use the established term Brugada Phenocopy to provide
consistency in the literature and facilitate future research.We are establishing an international registry database at www.burgadaphenocopy.com and invite
Gazzoni et al[1] to submit this case
along with future cases to the registry should they satisfy the BrP diagnostic
criteria[3]. The goal of this
registry is to provide long-term follow-up and insight into the pathophysiology and
natural history of patients presenting with BrP.
Authors: Adrian Baranchuk; Timothy Nguyen; Min Hyung Ryu; Francisco Femenía; Wojciech Zareba; Arthur A M Wilde; Wataru Shimizu; Pedro Brugada; Andrés R Pérez-Riera Journal: Ann Noninvasive Electrocardiol Date: 2012-08-13 Impact factor: 1.468
Authors: Natalia R Genaro; Daniel D Anselm; Nahuel Cervino; Ariel O Estevez; Carlos Perona; Alejandro M Villamil; Ruben Kervorkian; Adrian Baranchuk Journal: Ann Noninvasive Electrocardiol Date: 2013-10-23 Impact factor: 1.468